During the past decade, The Medical Research Network, LLC conducted 36 clinical trials. In the 10-year time frame, 36 clinical trials started and 34 clinical trials were completed, i.e. on average, 94.4% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 25 clinical trials were completed. i.e. 192.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Medical Research Network, LLC" #1 sponsor was "Pfizer" with 11 trials, followed by "Naurex, Inc, an affiliate of Allergan plc" with 5 trials sponsored, "Janssen Research & Development, LLC" with 4 trials sponsored, "Otsuka Pharmaceutical Development & Commercialization, Inc." with 4 trials sponsored and "The Medical Research Network" with 4 trials sponsored. Other sponsors include 26 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Medical Research Network, LLC" #1 collaborator was "APCER Life Sciences" with 1 trials as a collaborator, "AbbVie" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Forest Laboratories" with 1 trials as a collaborator and "KCAS Bio" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "The Medical Research Network, LLC" are "Major Depressive Disorder" (7 trials), "Depressive Disorder, Major" (6 trials), "Low Back Pain" (4 trials), "Osteoarthritis" (4 trials) and "Social Anxiety Disorder" (4 trials). Many other conditions were trialed in "The Medical Research Network, LLC" in a lesser frequency.

Most popular intervention types in "The Medical Research Network, LLC" are "Drug" (51 trials), "Biological" (8 trials) and "Other" (8 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (27 trials), "Rapastinel" (5 trials), "placebo" (3 trials), "tanezumab" (3 trials) and "CERC-301" (2 trials). Other intervention names were less common.

The vast majority of trials in "The Medical Research Network, LLC" are 59 trials for "All" genders.

Currently, there are NaN active trials in "The Medical Research Network, LLC". 1 are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 42 completed trials in The Medical Research Network, LLC, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in The Medical Research Network, LLC, 0 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 36 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 3 trials that are defined as “Not Applicable".